Pure Global

Performance of Aspheric Hydrogel Lenses After a Refit With Sphere Silicone Hydrogel Lenses for 4 Weeks - Trial NCT03835078

Access comprehensive clinical trial information for NCT03835078 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 42 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT03835078
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT03835078
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Performance of Aspheric Hydrogel Lenses After a Refit With Sphere Silicone Hydrogel Lenses for 4 Weeks

Study Focus

Ametropia

methafilcon A contact lenses

Interventional

device

Sponsor & Location

Coopervision, Inc.

Mexico City, Mexico

Timeline & Enrollment

N/A

Jan 01, 2019

Jul 06, 2019

42 participants

Primary Outcome

Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses,Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses

Summary

The aim of this prospective study is to evaluate the clinical performance of habitual wearers
 of methafilcon A aspheric lenses after a refit with fanfilcon A sphere lenses for 4 weeks of
 daily wear.

ICD-10 Classifications

Amblyopia ex anopsia
Amoebiasis
Amoebiasis, unspecified
Myoclonus
Oesophagitis

Data Source

ClinicalTrials.gov

NCT03835078

Device Trial